Boston Therapeutics Corporate Update
02 avr. 2012 15h57 HE
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Apr 2, 2012) - Boston Therapeutics Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, reviews the series of events that have led to the availability of its lead...
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
02 mars 2012 17h13 HE
|
Boston Therapeutics, Inc.
MANCHESTER, NH--(Marketwire - Mar 2, 2012) - Boston Therapeutics, Inc. (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased to announce that it has received clearance by FINRA on...
Boston Therapeutics Announces Clinical Study Safety Results With SUGARDOWN(R) at University of Sydney
24 janv. 2012 11h40 HE
|
Boston Therapeutics, Inc.
MANCHESTER, N.H., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (BTI), a developer of diabetes therapeutics, announced today the clinical trial results in healthy volunteers performed at...